Navigation Links
Accuray Announces Results for Second Quarter of Fiscal 2011
Date:1/27/2011

SUNNYVALE, Calif., Jan. 27, 2011 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today financial results for the second quarter of fiscal year 2011, ended December 31, 2010.

For the second quarter of fiscal 2011, Accuray reported total revenue of $54.2 million, a decrease of five percent from total revenue of $57.3 million during the second quarter of fiscal 2010. Total revenue during the second quarter of fiscal 2011 included $0.9 million of revenue previously deferred for systems sold with legacy Platinum service agreements, compared to $7.3 million in the second quarter of fiscal 2010.

Net income for the second quarter of fiscal 2011 was $4.1 million, or $0.07 per share, compared to a net loss of $1.2 million, or $0.02 per share, during the same period last year.

Net orders to backlog totaled $83.9 million during the second quarter: $53.6 million for systems and $30.2 million for service. System backlog totaled $170 million at the end of the second quarter, up 12 percent and 27 percent, respectively, from the prior quarter and prior year quarter. Service backlog totaled $240 million at the end of the second quarter, up 5 percent and 25 percent, respectively, from the prior quarter and prior year quarter. Total backlog was $410 million at the end of the second quarter, up 8 percent and 26 percent, respectively, from the prior quarter and prior year quarter.

During the second quarter 19 orders for CyberKnife® Robotic Radiosurgery Systems were added to backlog, two orders were cancelled by customers, and two orders aged beyond two and a half years and are no longer reported in backlog.

During the second quarter, 6 new CyberKnife Systems were installed, increasing the worldwide CyberKnife installed base to 222 systems.

"We are pleased with the continued momentum in generating
'/>"/>

SOURCE Accuray Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Accuray Hires Chief Marketing Officer
2. Accuray Elevated to NASDAQ Global Select Market
3. Accuray Incorporateds CEO to Speak at 29th Annual J.P. Morgan Healthcare Conference
4. Accuray Establishes Medical Affairs Function
5. Accuray Receives FDA Clearance for the CyberKnife® Systems Lung Optimized Treatment
6. Accuray Announces Results for First Quarter of Fiscal 2011
7. Accuray Announces Expanded Service Program
8. Accurays CyberKnife VSI System Featured at 2010 American Society for Radiation Oncology (ASTRO) Annual Meeting
9. Accuray Hires General Manager for the Asia Pacific Region
10. Accuray Incorporated to Speak at Oppenheimers 21st Annual Healthcare Conference
11. Accuray Incorporated to Report Financial Results for First Quarter of Fiscal 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... DIEGO , Sept. 18, 2014  Halozyme ... announced that the U.S. Food and Drug Administration ... enrollment and dosing of PEGPH20 in SWOG,s ongoing ... designed to evaluate Halozyme,s investigational drug PEGPH20 (PEGylated ... chemotherapy (mFOLFIRINOX) in patients with metastatic pancreatic adenocarcinoma.  ...
(Date:9/18/2014)... -- Australian biomarker discovery company Minomic International Ltd will ... prostate cancer screening test, planning to achieve US Food ... Minomic,s proprietary MiStat™ technology is a screening assay ... known as the MIL-38 antigen. This biomarker is present ... Researchers at 11 leading urology centres in ...
(Date:9/18/2014)... , Sept. 18, 2014 /CNW/ - A new expert panel ... Canada , released today by the Council ... and effective medicines for children. Each year about half ... use at least one prescription drug. Much of this ... the authorized use), creating potential health risks. ...
Breaking Medicine Technology:SWOG To Resume Clinical Trial Of Halozyme's PEGPH20 In Combination With Modified FOLFIRINOX For Advanced Pancreatic Cancer 2SWOG To Resume Clinical Trial Of Halozyme's PEGPH20 In Combination With Modified FOLFIRINOX For Advanced Pancreatic Cancer 3SWOG To Resume Clinical Trial Of Halozyme's PEGPH20 In Combination With Modified FOLFIRINOX For Advanced Pancreatic Cancer 4Minomic Launches US Pilot Study of MiStat(TM) Novel Prostate Cancer Screening Technology 2Studying medicines in children is always possible and is in their best interest, finds Expert Panel 2Studying medicines in children is always possible and is in their best interest, finds Expert Panel 3
... , BEDFORD, Mass., Aug. 19 Holo ... (Nasdaq: HOLX ), a leading developer, manufacturer and supplier of ... healthcare needs of women, today announced the publication of the first of ... both symptomatic and asymptomatic pregnant women at risk for preterm birth. The ...
... , JAMESBURG, N.J., Aug. 19 Phytomedics Inc. today ... 2b clinical trial with an extract of Tripterygium wilfordii Hook F ... in the August 18, 2009 issue of the Annals of Internal ... article entitled "Comparison of Tripterygium wilfordii Hook F versus ...
Cached Medicine Technology:Study Links Fetal Fibronectin Testing with Changes in Management Decisions for Symptomatic and Asymptomatic Women at Risk for Preterm Birth 2Study Links Fetal Fibronectin Testing with Changes in Management Decisions for Symptomatic and Asymptomatic Women at Risk for Preterm Birth 3Study Links Fetal Fibronectin Testing with Changes in Management Decisions for Symptomatic and Asymptomatic Women at Risk for Preterm Birth 4Phytomedics Inc. Announces Publication of the Phase 2b Clinical Trial Results of an Extract of the Chinese Herbal Remedy Tripterygium wilfordii Hook F in Rheumatoid Arthritis 2Phytomedics Inc. Announces Publication of the Phase 2b Clinical Trial Results of an Extract of the Chinese Herbal Remedy Tripterygium wilfordii Hook F in Rheumatoid Arthritis 3
(Date:9/18/2014)... The new BuildClean™ Dust Control ... and homeowners alike as it eliminates the top ... causes potential health issues, and makes it “unlivable” ... system allows contractors to virtually eliminate airborne dust ... remodeling tasks. , BuildClean removes up to 90 ...
(Date:9/18/2014)... 2014 T-System Inc. today announced ... documentation system — EV™ for physicians ... assessing several best-of-breed solutions, Holyoke chose T-System’s solution ... physician productivity and reimbursement, but also its ability ... still be used to capture emergency department, (ED) ...
(Date:9/18/2014)... Recently, WowBobble.com, the popular online supplier of funny ... to its product line. Moreover, all the company’s products ... customers can enjoy the special offer before September 29, 2014. ... prices ($12.5 for each bobblehead doll ). , ... bobbleheads. We want to make our interesting items available to ...
(Date:9/18/2014)... 2014 How much is a serving? ... the factors contributing to the obesity epidemic in the ... serving and how to manage portion size during the ... 3 at Humility House, 755 Ohltown Road, Austintown. , ... the informational discussion and answer questions from 12:30 to ...
(Date:9/18/2014)... Finding the perfect no carb diet ... weight loss struggle will never end. But, because Diet ... fast weight loss, patients can expect to see fast ... a recent in-house survey of over 20,000 actual patients ... during the first month without between meal hunger, food ...
Breaking Medicine News(10 mins):Health News:New BuildClean™ System Brings Livability Back to Home Remodeling 2Health News:New BuildClean™ System Brings Livability Back to Home Remodeling 3Health News:New BuildClean™ System Brings Livability Back to Home Remodeling 4Health News:Holyoke Medical Center ER Improves Productivity and Reimbursement with T-System 2Health News:Discounted Custom Bobbleheads Online For Sale At WowBobble.com 2Health News:HMHP Workshop Addresses Portion Control 2Health News:Diet Doc Discloses the Results of a Recent In-House Survey Revealing an Average Loss of 20 Pounds Per Month with Their No Carb Diet Plans 2Health News:Diet Doc Discloses the Results of a Recent In-House Survey Revealing an Average Loss of 20 Pounds Per Month with Their No Carb Diet Plans 3
... attention-deficit/hyperactivity disorder, is among the costliest of behavioral ... leads to accidental injuries, school failure, substance abuse, ... century of study, the disorder,s roots remain mysterious. ... on heritability of the condition, and indeed evidence ...
... Brigham and Women,s Hospital in Boston suggests that improvements in ... cases of ear infections in children. Ear ... with annual direct and indirect costs of $3 billion to ... "We believe these findings, which demonstrate a direct correlation between ...
... for suspected developmental delays , THURSDAY, Jan. 28 (HealthDay ... of screening children for developmental delays, many fail to refer ... "The ultimate goal of screening is to improve outcomes for ... that many pediatricians did not act properly even when serious ...
... , , URAC,s 2010 ... Programs , WASHINGTON , Jan. 28 ... organization, has issued a call for entries for its 2010 Best ... which companies are setting the standard in advancing the role of consumers ...
... , Emergency Relief Fund Established for Haitian Senior Living ... The Assisted Living Federation of America (ALFA) has ... of senior living companies. , "The employees of our members devote ... in their hour of need, we offer support to them so ...
... have discovered a new strategy for making embryonic stem cell ... system. This strategy, described in a new research report appearing ... Journal ( http://www.fasebj.org ), involves fusing bone marrow cells ... DNA from both the donor and recipient, raising hopes that ...
Cached Medicine News:Health News:Study says lead may be the culprit in ADHD 2Health News:Improved air quality linked to fewer pediatric ear infections 2Health News:Kids' Screenings in Place, But Referrals Lacking 2Health News:Which Health Care Organizations Are Advancing Consumer Protection and Empowerment? 2Health News:Which Health Care Organizations Are Advancing Consumer Protection and Empowerment? 3Health News:Which Health Care Organizations Are Advancing Consumer Protection and Empowerment? 4Health News:ALFA Extends Helping Hand to Haiti 2Health News:Stem cell breakthrough: Bone marrow cells are the answer 2
Inquire...
... The Trinity Biotech Captia™ Mumps IgG ... the detection and quantitative determination of IgG ... Individual serum specimens may be used for ... acute and convalescent, may be used to ...
... AUTOMATION, INC. (DAI) Mumps IgG ... intended for the detection and ... to Mumps virus in human ... be used for the determination ...
... Corporation announced the launch of the ... first bi-directional cooled-tip catheter available in the ... offers physicians the benefits of cooled ablation ... the Boston Scientific Blazer(R) catheter platform. ,Cooled ...
Medicine Products: